Related Experiment Video
Updated: May 11, 2026
09:40
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Identifying Ki-67 specific miRNA-mRNA interactions in malignant astrocytomas
Yanwei Liu1, Kai Tang, Wei Yan
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Neuroscience Letters
|May 7, 2013
Summary
This study reveals that microRNA-messenger RNA interactions regulate Ki-67 expression in glioma. Specifically, miR-218 reduces Ki-67, inhibiting glioma cell proliferation and promoting apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ki-67 protein is a key marker for glioma cell proliferation.
- Mechanisms behind abnormal Ki-67 expression in glioma remain unclear.
- Understanding these mechanisms is crucial for targeted therapies.
Purpose of the Study:
- To identify specific microRNA (miRNA)-messenger RNA (mRNA) interactions related to Ki-67 expression in glioma.
- To elucidate the role of these interactions in glioma cell growth and proliferation.
Main Methods:
- Large-scale miRNA and mRNA expression profiling in primary glioblastoma multiforme (pGBM) and anaplastic astrocytoma (AA) tissues.
- Utilized target prediction databases to establish miRNA-mRNA targeting relationships.
- Performed functional verification of candidate miRNAs in the LN229 cell line.
Main Results:
- High Ki-67 protein levels correlated with shorter survival in AA patients.
- Identified 4 positively and 5 negatively correlated miRNAs with Ki-67.
- miR-218 was identified as a key regulator, with its up-regulation reducing Ki-67, promoting apoptosis, and inducing cell cycle arrest.
Conclusions:
- Specific miRNA-mRNA interactions, particularly involving miR-218, likely regulate Ki-67 expression in glioma.
- These interactions play a significant role in glioma cell proliferation.
- Findings suggest potential therapeutic targets for glioma treatment.
